Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
-
Let’s talk about it! Thai partner broadcasts on Facebook Live for World AIDS Day
NewsDiscussing the issues and facts head-on in order to reduce HIV-related stigma in Thailand. Story first published on The Nation,...
Read more about Let’s talk about it! Thai partner broadcasts on Facebook Live for World AIDS Day
-
São Paulo protest exposes how Gilead’s actions block access to medicines around the world
NewsIn São Paulo, on 31 October 2017, activists from around the world held a protest at the headquarters of...
-
-
HIV activists trained on intellectual property and access to medicines
NewsDemystifying intellectual property (IP) and providing advocacy tools. The International Treatment Preparedness Coalition – MENA (ITPC-MENA) with the support...
Read more about HIV activists trained on intellectual property and access to medicines
-
The Indonesian patent club – and its impact on Hep C treatment
NewsCommunities are refusing to accept patent abuse – challenging unmerited patents, and finding ways around them in the meantime. Community...
Read more about The Indonesian patent club – and its impact on Hep C treatment
-
Myanmar: Creating an intellectual property law that protects public health
NewsLobbying for an intellectual property law that doesn’t just serve big business, but protects public health and encourages innovation in...
Read more about Myanmar: Creating an intellectual property law that protects public health
-
The Network vs. Abbvie – the first victory in reducing cost of HIV drug
NewsThe first victory has been won – and our partner in Ukraine intends to see the case through. On 4...
Read more about The Network vs. Abbvie – the first victory in reducing cost of HIV drug
-
Brazil: 10 years of a Compulsory License on HIV drug Efavirenz
NewsSymposium in Curitiba highlights the need for a collective fight to make medicines affordable. When governments are unreceptive, it is...
Read more about Brazil: 10 years of a Compulsory License on HIV drug Efavirenz
-
Patients demand AbbVie’s price bubble is burst – key HIV drug out of reach
Call to action NewsAbbVie’s monopoly has hiked prices – it’s time to burst the bubble and get prices back down to earth. Activists...
Read more about Patients demand AbbVie’s price bubble is burst – key HIV drug out of reach
-
Malaysia paves the way for compulsory licensing on hepatitis C medicines
NewsHistoric decision will cure more hepatitis C patients – and other countries can follow suit. Today, 20 September 2017, Malaysia’s...
Read more about Malaysia paves the way for compulsory licensing on hepatitis C medicines
